<SEC-DOCUMENT>0001193125-22-005128.txt : 20220110
<SEC-HEADER>0001193125-22-005128.hdr.sgml : 20220110
<ACCEPTANCE-DATETIME>20220110081532
ACCESSION NUMBER:		0001193125-22-005128
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220110
DATE AS OF CHANGE:		20220110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Magenta Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001690585
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38541
		FILM NUMBER:		22519795

	BUSINESS ADDRESS:	
		STREET 1:		100 TECHNOLOGY SQUARE
		STREET 2:		5TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-201-2700

	MAIL ADDRESS:	
		STREET 1:		100 TECHNOLOGY SQUARE
		STREET 2:		5TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d200809d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mgta="http://www.magentatx.com/20220110" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-01-10_to_2022-01-10">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-01-10_to_2022-01-10">0001690585</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="mgta-20220110.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-01-10_to_2022-01-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690585</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-10</xbrli:startDate> <xbrli:endDate>2022-01-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-01-10_to_2022-01-10">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt:datemonthdayyearen">January 10, 2022</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2022-01-10_to_2022-01-10">MAGENTA THERAPEUTICS, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-01-10_to_2022-01-10">001-38541</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-01-10_to_2022-01-10">81-0724163</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-01-10_to_2022-01-10">100 Technology Square</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-01-10_to_2022-01-10">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:stateprovnameen">Massachusetts</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-01-10_to_2022-01-10">02139</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-01-10_to_2022-01-10">(857)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-01-10_to_2022-01-10">242-0170</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-01-10_to_2022-01-10">Common Stock, $0.001 Par Value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-01-10_to_2022-01-10">MGTA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2022-01-10_to_2022-01-10" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following information and Exhibit&#160;99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;10, 2022, Magenta Therapeutics,&#160;Inc. issued a press release providing a business update including highlights of recent progress across several programs and platforms, milestone expectations for fiscal year 2022, preliminary unaudited financial results for the full year ended December&#160;31, 2021 and projected cash runway. The full text of the press release is furnished as Exhibit&#160;99.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;Exhibits: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following exhibit relating to Item 2.02 shall be deemed furnished, and not filed: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:94%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d200809dex991.htm">Press Release dated January&#160;10, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:10%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:89%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">MAGENTA THERAPEUTICS,&#160;INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">January&#160;10, 2022</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stephen Mahoney</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Financial and Operating Officer</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d200809dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g200809g21v11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>-- <FONT STYLE="white-space:nowrap">MGTA-117</FONT> Phase 1/2 clinical trial is open for enrollment for patients with relapsed/refractory
acute myeloid leukemia and myelodysplastic syndromes; clinical data expected in 2022 &#150;- </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>-- CD45 antibody drug conjugate is
Magenta&#146;s second conditioning program; dose range toxicology results expected in second half of 2022 -- </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>-- <FONT
STYLE="white-space:nowrap">MGTA-145</FONT> stem cell mobilization program focused on dose and administration optimization and sickle cell disease clinical trial with initial data expected in second half of 2022 &#150;- </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>-- Focused program spending allows for extended cash runway; ended 2021 with approximately $162&nbsp;million in cash reserves with
expectation to fund operating plan into Q4 2023 -- </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CAMBRIDGE, Mass.--(BUSINESS WIRE) -- Jan. 10, 2022&#151;<B>Magenta Therapeutics</B>&nbsp;(NASDAQ:
MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients, today highlighted progress across its portfolio of targeted conditioning and stem cell
mobilization programs and set out its milestone expectations for both clinical and preclinical data in 2022. These updates will also be discussed during a webcast presentation at the 40th Annual&nbsp;J.P. Morgan Healthcare
Conference&nbsp;on&nbsp;Thursday, January&nbsp;13 at 9:45&nbsp;a.m. EST. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;2022 will be an important year for the Magenta portfolio&#148;
said&nbsp;Jason Gardner,&nbsp;D. Phil., President and Chief Executive Officer, Magenta Therapeutics. &#147;We believe we will clinically demonstrate that <FONT STYLE="white-space:nowrap">MGTA-117</FONT> targets and binds selectively to
CD117-expressing cells, potently depletes those cells and the product profile will be well-tolerated in our Phase 1/2 clinical study. We have developed biomarker assays that </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
we believe will provide early insights into the biologic activity of <FONT STYLE="white-space:nowrap">MGTA-117.</FONT> We are also thrilled to introduce our second targeted conditioning program
in the development pipeline, an antibody drug conjugate targeting CD45 which has the potential to deplete both stem cells and immune cells without chemotherapy. Finally, with our <FONT STYLE="white-space:nowrap">MGTA-145</FONT> program, we are
focused on optimizing the collection yield of mobilized stem cells. We believe <FONT STYLE="white-space:nowrap">MGTA-145</FONT> can offer a faster and more reliable mobilization regimen for stem cell transplantation as well as <I>ex vivo</I> and
<I>in vivo</I> gene therapies.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Targeted Conditioning </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">MGTA-117</FONT> Program: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2022 Clinical Data from Phase 1/2 Clinical Trial: Evaluating Target Selectivity, Potency and Tolerability</I></B><B>. </B>The <FONT
STYLE="white-space:nowrap">MGTA-117</FONT> Phase 1/2 clinical trial is open for enrollment. This dose escalation clinical trial will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of
<FONT STYLE="white-space:nowrap">MGTA-117</FONT> as a single dose in patients with relapsed/refractory Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts <FONT STYLE="white-space:nowrap">(MDS-EB).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Specifically, dosing cohorts expected to enroll in 2022 will allow for evaluation of <FONT STYLE="white-space:nowrap">MGTA-117&#146;s</FONT> ability to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">selectively target CD117 as measured by receptor occupancy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potently deplete CD117-expressing cells such as stem cells, progenitors, and tumor cells; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rapidly clear from the body with a well-tolerated profile as determined by pharmacokinetic analysis and clinical
chemistry tests, respectively. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta&#146;s preclinical evidence supports the <FONT STYLE="white-space:nowrap">MGTA-117</FONT> target
selectivity, potency and tolerability profile. In GLP toxicology studies, <FONT STYLE="white-space:nowrap">MGTA-117</FONT> potently depleted stem cells at a dose level where there were no drug-related findings in hepatic, reproductive, neurologic,
cardiovascular, or respiratory organs. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Phase 1/2 Clinical Trial Design for <FONT STYLE="white-space:nowrap">MGTA-117</FONT></I></B><B>. </B><FONT
STYLE="white-space:nowrap">MGTA-117</FONT> will be assessed in patients with relapsed/refractory AML and <FONT STYLE="white-space:nowrap">MDS-EB</FONT> in a multi-center, open-label, single-ascending-dose trial. Patients in the first cohort will
receive 0.02 mg/kg administered intravenously (IV), and subsequent cohort doses will be determined in accordance with a modified Fibonacci sequence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta will assess data from each cohort and, after collection of adequate safety, pharmacokinetic and pharmacodynamic data, Magenta intends to engage with
the U.S. Food and Drug Administration (FDA) to transition to the primary target population of patients eligible for stem cell transplantation. In addition, Magenta plans to explore <FONT STYLE="white-space:nowrap">MGTA-117</FONT> as a targeted
conditioning agent for stem cell gene therapies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CD45-Antibody Drug Conjugate Program: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta has initiated investigational new drug application-enabling studies on its second targeted conditioning program, an antibody drug conjugate (ADC)
targeting CD45. Due to the expression of CD45 on stem cells and immune cells, Magenta&#146;s <FONT STYLE="white-space:nowrap">CD45-ADC</FONT> is designed to selectively target and deplete stem cells and lymphocytes, which could allow patients with
blood cancers and autoimmune diseases to avoid use of chemotherapy prior to stem cell transplant. Magenta expects to have preclinical data from a dose ranging toxicology study in the second half of 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Stem Cell Mobilization and Collection </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">MGTA-145</FONT></B><B><I> </I></B><B>Dosing and Administration Optimization Clinical Trial. </B>As previously disclosed, Magenta intends to initiate a dosing and administration optimization clinical trial with <FONT
STYLE="white-space:nowrap">MGTA-145</FONT> in combination with plerixafor. Clinical data from a Phase 2 investigator-initiated clinical trial with 25 multiple myeloma patients showed that MGTA-145, in combination with plerixafor, mobilized a
sufficient number of stem cells for transplantation in 88% of patients (22/25). In addition, all patients transplanted with cells mobilized by <FONT STYLE="white-space:nowrap">MGTA-145</FONT> plus plerixafor as of the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
data <FONT STYLE="white-space:nowrap">cut-off</FONT> date had successful engraftment (18/18 patients) with prolonged durability through the <FONT STYLE="white-space:nowrap">100-day</FONT> <FONT
STYLE="white-space:nowrap">follow-up</FONT> period (13/13 patients). The regimen was generally well-tolerated. Magenta believes there are specific opportunities to further improve cell collection yield by adjustments to the regimen dosing, and
administration timing. Magenta expects to generate data from this healthy subjects clinical trial in the second half of 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sickle Cell Disease
(SCD) &#150; Stem Cell Mobilization Phase 2 Clinical Trial. </B>Magenta is advancing trial initiation activities. The trial is designed to evaluate mobilization and collection of stem cells in adults and adolescents with SCD. Magenta and its
clinical collaboration partner, bluebird bio, will each characterize the collected cells. Magenta plans to gene-modify the cells and transplant them into established preclinical models to evaluate graft quality and engraftment. Data from this
clinical trial could provide <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> for <FONT STYLE="white-space:nowrap">MGTA-145,</FONT> in combination with plerixafor, as a first-line mobilization regimen
for patients with SCD and, more broadly, across other gene therapy applications. Magenta expects to generate data from this clinical trial in the second half of 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Cash Guidance </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With focused allocation of capital
and resources on both clinical stage programs and <FONT STYLE="white-space:nowrap">CD45-ADC,</FONT> Magenta now expects its cash reserves to fund its operating plan into the fourth quarter of 2023. Magenta ended 2021 with approximately
$162&nbsp;million of cash, cash equivalents, and marketable securities (unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Magenta Therapeutics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta Therapeutics&nbsp;is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplant to more
patients with blood cancer, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise to revolutionize immune and blood reset to allow more
patients to take advantage of the curative potential of stem cell transplant as well as potentially improve eligibility for future gene therapies. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta is based in&nbsp;Cambridge, Mass.&nbsp;For more information, please
visit<B>&nbsp;<U>www.magentatx.com</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follow Magenta on Twitter: @magentatx. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may
contain forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 and other federal securities laws, including express or implied statements regarding Magenta&#146;s future expectations, plans and
prospects, including, without limitation, statements regarding expectations, plans and timing for preclinical activities, clinical trials and related results, the development of product candidates and advancement of preclinical and clinical
programs, the potential benefits and expected performance of product candidates, projections regarding long-term growth, cash, cash equivalents and marketable securities, as well as other statements containing words such as &#147;anticipate,&#148;
&#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;designed,&#148; &#147;endeavor,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;potential,&#148;
&#147;predict,&#148; &#147;project,&#148; &#147;seek,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will&#148; or &#147;would&#148; and similar expressions that constitute forward-looking statements under the Private Securities Litigation
Reform Act of 1995. The express or implied forward-looking statements included in this press release are only predictions and are subject to a number of risks, uncertainties and assumptions, including, without limitation: uncertainties inherent in
preclinical and clinical studies and in the availability and timing of data from ongoing and planned clinical and preclinical studies; the ability to initiate, enroll, conduct or complete ongoing and planned preclinical and clinical studies; whether
results from preclinical or earlier clinical studies will be predictive of the results of future studies; discussions with governmental agencies such as the FDA; the expected timing of submissions for regulatory approval to conduct or continue
trials or to market products; whether Magenta&#146;s cash resources will be sufficient to fund Magenta&#146;s foreseeable and unforeseeable operating expenses and capital expenditure requirements; risks, uncertainties and assumptions regarding the
impact of the continuing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on Magenta&#146;s business, operations, strategy, goals and anticipated timelines, and other risks concerning Magenta&#146;s programs and
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operations are described in additional detail in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed on&nbsp;March 3, 2021, as updated by Magenta&#146;s most recent
Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and its other filings made with the&nbsp;Securities and Exchange Commission&nbsp;from time to time. Although Magenta&#146;s forward-looking statements reflect the good faith
judgment of its management, these statements are based only on facts and factors currently known by Magenta. As a result, you are cautioned not to rely on these forward-looking statements. Any forward-looking statement made in this press release
speaks only as of the date on which it is made. Magenta undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investor inquiries: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leah Monteiro </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Magenta Therapeutics </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>lmonteiro@magentatx.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgta-20220110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 1/10/2022 12:33:21 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  xmlns:mgta="http://www.magentatx.com/20220110"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"

  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.magentatx.com/20220110"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />

    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgta-20220110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgta-20220110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mgta-20220110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 1/10/2022 12:33:21 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mgta-20220110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 1/10/2022 12:33:21 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mgta-20220110.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g200809g21v11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g200809g21v11.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MRI(BNC*R,-RLK*05/0@J2"".XKCLUHURM=#ZE--)P]Y/:Q*/\_A1M\AK[K=
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AM*4M?.[?=L]L'&/;^E8[>5CQ=OD% !0 4 % !0 4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140083744806088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001690585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 10,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MAGENTA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-0724163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Technology Square<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">242-0170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGTA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d200809d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgta-20220110.xsd" xlink:type="simple"/>
    <context id="duration_2022-01-10_to_2022-01-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690585</identifier>
        </entity>
        <period>
            <startDate>2022-01-10</startDate>
            <endDate>2022-01-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2022-01-10_to_2022-01-10">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-01-10_to_2022-01-10"
      id="Hidden_dei_EntityCentralIndexKey">0001690585</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-01-10_to_2022-01-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-01-10_to_2022-01-10">2022-01-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2022-01-10_to_2022-01-10">MAGENTA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-01-10_to_2022-01-10">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-01-10_to_2022-01-10">001-38541</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-01-10_to_2022-01-10">81-0724163</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-01-10_to_2022-01-10">100 Technology Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-01-10_to_2022-01-10">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-01-10_to_2022-01-10">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-01-10_to_2022-01-10">02139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-01-10_to_2022-01-10">(857)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-01-10_to_2022-01-10">242-0170</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-01-10_to_2022-01-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-01-10_to_2022-01-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-01-10_to_2022-01-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-01-10_to_2022-01-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-01-10_to_2022-01-10">Common Stock, $0.001 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-01-10_to_2022-01-10">MGTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-01-10_to_2022-01-10">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-01-10_to_2022-01-10">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2022-01-10_to_2022-01-10">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ME9C1<N(V%(:OMT^A87K1SB2Q)2"0'<(,(21+=Y-E [L[TTXOA"U $UMB93G
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M4$L! A0#%     @ [T$J5#2J#J+N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ [T$J5)E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " #O02I4PP$+WU8$  #9$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ [T$J5)^@&_"Q @  X@P
M  T              ( !F0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #O
M02I4EXJ[',     3 @  "P              @ %U#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " #O02I4'#AEZC\!   \ @  #P              @ %>$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ [T$J5"0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ [T$J5&60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d200809d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d200809d8k.htm">d200809d8k.htm</File>
    <File>d200809dex991.htm</File>
    <File>mgta-20220110.xsd</File>
    <File>mgta-20220110_lab.xml</File>
    <File>mgta-20220110_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d200809d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d200809d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mgta-20220110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgta-20220110_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mgta-20220110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mgta",
   "nsuri": "http://www.magentatx.com/20220110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d200809d8k.htm",
      "contextRef": "duration_2022-01-10_to_2022-01-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d200809d8k.htm",
      "contextRef": "duration_2022-01-10_to_2022-01-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.magentatx.com//20220110/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-22-005128-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-005128-xbrl.zip
M4$L#!!0    ( .]!*E07BV+W1@\  ,!A   .    9#(P,#@P.60X:RYH=&WM
M'&ESXD;V>ZKR'[J8G91=94 "; ,^4@YF9M@9'P7,)K5?4HW40&>$I.EN&=A?
MO^^U)! @+AN;<>*I2HS4U^MW']TZ_W4T<,@#$Y)[[D7&S!D9PES+L[G;N\@$
MJILM9\BOES__=-Y7T!$ZN[)J,WZ1Z2OE5_/Y44<X.<FL7,][R$-#OF 4C*QA
M9HMF)NH>R*P:^TQ.QG2I[.0\T<O'+2F#7,]U@\%DR' XS.FE<)BM1!['Y:%3
M%GHQP:UXW,CA[K>98<.B'F16*I6\;HV[+O2<+% PC&(>FSM4LKC[H*?H3/<!
M[3%7437*6=X MU P3-.8 ")Y&A@PM9G_X^9+R^JS <UR5RKJ6I-% B66@E3)
M0VO<D4NO5#!/5\ ?]9@,&"WK:T)?%W;+_OBM^67:7:7WGW;-*T%=V?7$@"K@
M'ISI.&L4LH63Q"19X(V9B6)>63=/.<$,N#A?M=4Y+&*K/<>C4>>3?-@8=5W.
M*<CO&<WXC-KX5W'EL,MR]O-Y/OP)[P9,48(S9-GW@#]<9&J>JX ILFU@SPRQ
MPJ>+C&(CE=<SDCR.RT>3$D+..YX]OCRW^0.1:NRPBXS-I>_0,8H RUR2<SZJ
M8G<FHM_<MID;_H8NMR'_$Y<.<"SCU:L!<VWX3WUP:"\"8J2:K O-@= X_A.Y
M%07.-/Y47N(I<]FECF3G^9G)%Q;C]D7FDX;C3UCQS[H+&!G78$E!G89KL]%G
M-LXD0%K284O0#)"=DXIQ7#Y>A"\_AQG!NDR )F,2GE&4JU)+'*Q%M!:HH@:Y
MR$@^\!UD'/VN+Q 4E/1L+,^YD;3C9BHLX2&)-E8:SZ".+L_SL_N)=C^S8_TL
MO4"$CUJ JA&Z-?4V0'<\C&GB31ZYC2^ZG FB06"IXEUK?)XEV/Q@A#IU?A\H
MZMF31Y!LH:ZI8I=3V.*1T[8IK/:2OG'+9-G).OD9[$RP.<5>/BF!>9!4^).0
M5QR5I0[ON54+]L)$9K9]R&W5KY9SQ]P]2_1U6%>=#:CH<3>+OZN$!LJ+WPC>
MZT>O<#H_G@R59K;/="M8:W\RA?+\:N*QXRGE#?2;CB< ]/B-Z8^(]!QNDW>&
M_I>Y_.6=>6*<G>?]90L5UR]4>/1"B6E+, E9W #I FFRDO^/5<WRY+E+!]P9
M5]M\P"2Y94/2] ;4/=-MPQ#NCN?89RGD^7K;:->O2:M]U:ZWEH-CO! XK7KM
M:[/1;M1;Y.KVFM3_J'VZNOU8)[6[FYM&J]6XNWT2C(5=P/C[5>M3X_9C^^[V
MB%SG:CE2,(Y+E3FXYA9=QYFS#+%.HE(Y\^11G)DSH-LL<YZ%4EHPWR_N?D,I
MG6XF5A)I! O)\0)<]>&N>4/.I4_=B2+J<\6R\,9B8#R'@OI@3)9Y$=>>%: 3
MD?!D-K?4VDN:-='G>03E\HUCGH5C=B+CH(6:]=LV:=;O[YKM_>N<^T#(@+J*
M*(^TF(4\1\PB\00QCP_LP_T#Z'6)ZC.$+1!<<1A_92D";\U*L;0<O!<C*#H\
M"$Z3^9Y0Y"!^9A0<'B8580_0DPC=S.S#ZO*@(E8']]IKJH?.U+9Z@81!WD4&
M L.J#1,,8'C?IN,Q0,3<S.6_J1M0,2:F<41PW*(2>=,>N]<>A=(NF&TY[X31
M7Y/UN,107]U"R]8FY>;J(^BF*]+^5&]>W=>_MANUUA%IW-9R*<'@$Q2#L0M<
M'-1'%#0!H@#E34RV3J@DTF<6AD VX2[A2A*K#V$,$_,*[8V[EW#W4Q"#B1S:
M<1BQF..@*Z03G:":\-FGMAT_1VM%>[4\QZ&^9-7XQVH>23 4^G(A-DS#>!_A
MKFI$8%:-.,1#P$3XQYZ-'(NE]QCT*WNN]8$)Q2WJ1-@--YS:,YJGL,4\,<SI
M0^8GA/]%L(NXBT][+-L1C'[#)"?$_57ZX &';(PX4Y-N=EV2X"8RPTY5S4AD
M;B_ $P!AT@>>E]X5'G"HMAJNY0FPCUH_M108K9H7N$J,:Y[]) .(F5',8"CF
M"^\!ET4+>,T<.@1CN-1]WI0-8IY?Z/\L.'QTF!$B^0-W&+1U0#=MGQ0TL\7R
M<<E<BK&_,^+:=-2(4FJ6QM0CL5@VL\9IH62>%#= XW-(>WE'POY8N[^3D/M
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MK)O(]F($&*6"(6Z\TY=<19HW-ZF%O$:?KKC"ISO/AQ^,UY^3O_P_4$L#!!0
M   ( .]!*E1Y/T_QN10  ,M+   1    9#(P,#@P.61E>#DY,2YH=&WM7&U3
M&TF2_JX(_D,%>[L!$9) V)ZU 1,K$+;9 YL!9N;VOI6Z2U*9?MNN;H'FU]^3
MF=6MEA!O#IN[B//$A$&E[NJJK'QY\LEL]C]=G9T>['\Z[@\.UEK[5R=7I\<'
MQ__5>?>NV]O?DH\8W_(7J/W#+X-_J<./1U].OUR\7__CT\G5\?J!6FOAHB.3
M%"8_V!^<_*XNK_YU>OQ^_<:&Q63W;?>-3=:5CNPX>;\>F5&QSG.=5Y?%.A_;
MI%.DV>YV5NPI_WF8%D4:R] H38J.LW^:W=[\\TC'-IKM7MG8./79W*B+--9X
M4O_TY./G]^NY'4_PJ/W#@^/;B1W:0M&VU/[6X<'^UOE!8P&-V7<P^])Z[BQG
M_>!OR=!E>S0+-G[?/E;<1X+"'2=G']7EQ='[]?'.]O;;[7?CG=ZTU^M^S<:T
M^*OWZZ=?/GX1(2TNM/$$7NGW$E7 9\>R.M-C?-#J:F)RG9FRL(%3GR#*B,3I
MU(6AB]6YS4QD$Z/.\W2<&^>43D)U9B/CBA3#Q[>9"0I=V#1Q6$*N=K9W=FK9
MWR.U'[.GDX-.1^U_^/+YJM;+B2U,QV4Z,+M)>H-]KA^<?;SJ=WJ]O^]OT94'
MZGRBG5&]K1T58)\VT)$J<HM_K5-I9A+>E$GR-(IB$@A]S+!?_.[4C2TF*C>1
MSIP)MW(SRG50I/ELK:6#LC JGIDHM:&*3'EM8JM9>#P8SEP6:0>I*S=+PCS%
MYO;F2P@UCL:P;$VH;")B_=M?>F^V][#)K9-EU7X9Z1X-7K_!'@H[Q 94F)=C
M%:3)UW*LL5GKUEI>J[#0U[_L.>4,O@[IFM"2BMADK#)2)!WOJ3"%X'.=C(TJ
MTEL;I%$ZGD&:KHP@VN;F_303'8U4.A)9=/X7Q2!*MM9Z5,U>OZG4S!4F5H&)
M(A6G0QO9/]ED*F%@#4$)%5(88K&0GN@PAC:X(I=+TZRP<74??>]L<!T9F32T
MSI >+^DPZR=&"KM*IU:)=5G%7MZ"/WA15*)Q,,*0%$='47HC3L;<%AC$18%V
M,, RN=&S/25#V$9/-JXSS'%K8RAG-%/_T?ME1_PY%A.1$"$"N=\XDT^-F/-:
MR\Q=&A13C4K(")Z CH'4-])T)[[X]34]Z]4+:>+!4?_L\.)D\/&XK<ZT<]U.
M9^/PM\N3S\>7E^J/DXOC35K(/W725;WM-A\FG65O[QY?3RY:Q+'QN7\YZ/^Z
M"^N%TFZVE:[5J.,*W*J&-BU,,$G$0H,TSG0"\S=3.+*,A)*D^%7%)K0!8H7#
M5PX@ (<!,0USNJ*80#E+DN'4J"R],3FIW-PJH.4)>41X6-P3I[FIO6P;(Z&>
MJ4D5G"KEX&@4Y"E^6'B,+,V+48J3I9D+2-O0E0N^A\VF>N9::Y4I2H!SIE!I
M6?"\<1WLS'*PPV%.YC9'-V:Y673BWG=W2?@PT#+#**L:-JTC!_D8LE[H/"E]
M6+*TM+HQ0^AF0?,Y.CNQ^H+E^'H;3^TG2:DC.<%_=L^[ZBS-QU#-3T9'Q230
MN5EK':7)R.0F"8Q<ER;R\VI2Y@XB;9.^E#J?R7#O%3WAW>[K-_)9=^.N.KZ\
MZOYH>') \>+O>^R 6#!#\H#*QG2DI!(SHW,6.&V_TN;ZO.GNMWMK+:=MZ 6B
M'<3U4>=A8O*VC VZB/4VZK8!9:">(05S.K&CB34CX!B#B$W*^64TL@'N4JNL
MIJMDJ7_ *("+8 $X*5ES=>P1648,#2''C= V@4R?C4I$?447AS8)*91&T#TL
M$/,7*<YV@,L[T$@R ](94FG82@9330I>1!894K5B0A&%O^;Y2(90]K ,2+W2
M$=2[EOH-KL*Y1N3M)$BD9;X*([FB#&==!3E,-(3@?8&AU>)(\VO8-YR4GCDO
M  DE6T@:X"A]"@'<R__O9YAN%IE%Q3+Q';VBH0RGTAGF1E]WA@8J879U!._O
M"$;O?[I0ER?_#1F_6J^FY!1F]R_O^+]U>,K!U:?WZ[WM[;_6\>?H^//5\<7_
MN?P&D]\TU(Q.",<UA>8JF -.V"9.L#J'(SI6"!\N&IA2DZK88D:N\,G*UZVT
M#Z<*_R'NJ9CD>+*X<CR']<:P5GCXL-K3>F^ZUH(*T<J\@C"$SGQ.T28COP]-
MRK0T%8-.K#N80-><J"\K.8$:K,HKNCCCVKN+KMLX+I-*^2F\DU,/)K#/@JT:
M*OS!)F2T;<$,M+$G"FP.[OQFV^0+V/$VX)R';74,1!Y!=HQO9M9$(1V0#T.F
M$9L<FU9U]L]>4 #!IJ,1&:$:(8S0+Y1Y4%A%NF+U$#:_$/UR,X;Z2;:S*BK[
M .380]!/@#5SJZ9VFA+XH>DIX3W <==C<)_D_TC.UKBNN.F'8LG;[V$UP#O[
MOQU<55IYU-3*_:W?#A[)37_Y7FMX=B(J2K3[6/+\W19X<L !]ZARZ0."*R-D
MH@U_7W]Y1?G$KCJ>ZJ@4("P25I<^+L'9(+*2708S5K8KCB*D8L5,\/$A/;;+
M^T-,?7H6]<W).H$N?,,9E7&X6K3X3I($C3:R,=97Y?3(T':*QA8062<ZCW60
M7L-U,5O">,\/AK,$HL9@.L*Y/??L84]:412'6?)J84:/D@RJSQS#F><83BN.
M8:-_=KHI-$V#:;"Z<WP;$&0^)-[!/>Y4-LX&EYWCP\TZ+/SH?/#@$O#:C@1$
MM4D0C&O2"8!>@Q" RY<CKGD1#Z:1'HH">"4E[_N,\.=)B_I,Y-SQN-T[.Y_O
MZI=G\H@$=Z[ZAZ?'U52'7RX&QQ<=P)33_OGE\6[URX.B6I;KNI)IWJ]OKZNC
MX]/3\_Y@</+Y8_WY\KQ_5'UN0B!9SX6 )?5>K3?@%<&+$/!J"NWR%PZJF]_\
M=;ZIJ\'2EZ\ K7[WV I"J7&60"82\[M5M_66;EOQ@.9$B]=21%GXUHM7+1Z.
MNE])GRCI@P4@+CZ0L3@9<6RT*W-"P41D!2:#G:HT"$HDS,%,8A_O!_]<T#^D
M"3\UZZ=F\5DNIVYJ=8ZG7 DH#&V;H\4V0U"36.B;:TN65P+MR;=['IVM5+Z5
MY9&?NO?_3?<(HX=0O2!BJH50(">4E)D)F;K,#534@2:Z#QE&;!-Q?$LX"<JG
MHYFS@I<J[+76HBR,V&UX4>.(Y8.29Y5G[=[C*G\D";54NV@R>8:R[@1YKRNS
MC-%(,7ER6K;,ZJRU7!,S9PW,W 2<E8"[ZB11'T_/FT428E^04K6?OX1E'Q,N
M9,P%CIGQ9T3I.I)NDTL&1\P0_DE23M,[A$;IWI%E:IX8"#4QA%@#.D?/+N$D
MVRHQ92ZD1!MGKO/0IE/M@C+2>5O!0]&I6V@4 5IF,%WW)UOT[2G=?:F;&C E
MS_CXN4IS)WO[ALRMIG6=,\QT/RW#.3MENWA\Q9RJ5 _#W%K%9538CM26VIP=
M=B(]-%';)UH=:*%4ECJL\IP,=M5YM2A/7(UL[@J?A/ NUEJ$[(@IWNYN[ZAX
MO'4]KFMU)N>M%;F>FB0M'0QMX^3W30G)KAPZ\^^2*# _'SW8U;)IN%':01"D
M>:C)ZW@''*<ALB-\^\$.TP3?6R7S!:;[XY.SB@Z79(N/42H<'"R,!B;QN\)>
ML>$1L4X-N@NIF ZQ7$JRJP3[;JBXDU'S,^9D/&1KB [G)'!,Q2DIVM%1_=:]
M[*H/:1KR/ /B$_N+-=2-#X/^)MW+Q):M2GS"B%M(J(;T69J549U#UIIJ8,Z6
MR+,'>3)VV3H4WFF^=KI 5GZ;143%?1M/4!&N<*<+M:UQU9XP7]<2 _<2W!NQ
MM9U^1>KR(1S5I.Z+<ER5V(DTEAJXE#2F@!MVS <%OYC@!J:>=99%\)<TW#&)
M'D8D5!]HB<BE4N!3*.\'6>V-_N!H$]JZ0&YWU: TE1Y6:%\4C[EO_/H K5WK
M5P5<'M4J.:+!4>TN%PNV*Q)<>F:5E"PM)9K%V20-9@7!$6'I@[2,0L_'+/CX
MM=8P(O,,R*OE<K\NB]1OQS<QL(DP/E<E_#*DT"3LR5"I$)BN-+]N;6Q"%_%<
M7*&Z4YAEMZ7G72C,T"]"K%D5!%9T2CSL<;\CDWU)VSRB;9XU"7LN7<Z]:Y/9
M7FWAWY?8?D[SB\<.0">J 24&0N_1/I:\])=FI\LBC!'\T6=T/K428*EZ'N$4
MPY51HK)\.>KJB0_UUJSJH?F&CA_J+DGCH4UD5IX&%I3;6PTGW9UOK*F- M]V
M&EXJS3MSY[5J:3MO!.IDD>\WB_7<ZMPDO2&KIAILM<#V(TMK-PI2&LE*205Q
MFDXE93Q<:MR0/HCE.A$>\/;M7Q<BY\;.SM;.F\VET*BIJ%E=,I\%3^9%R1/F
MRT%V^?SB7%2ZQNXHAE)_R,0((_(SSWAV59H5]M%S",JBDXY&U3%0VPL<**'@
M@,H0HS(B!)<#)W)1>*/W=JOWME:&3:^5E#LF8^F,J1GY29Z6X\G3<G#(M!/J
M65W#>-R01RE%KDZ9U1H$W4'4VNB]VNJ]FJ^06WKJPND-](K@5LX=((M<R3PJ
M^8JN\TDU5=F=+WK "1&U4)*Q2PP<E3E=1GTP>3KUG7YW"LBP"1U^+1V+T54P
MHEJ6^+RV,(!+7H]\7C)>&3)E)SBQN7,JJ)0VX>ZB&:4R7_G:Y3K<(_'R1_(W
MB"F7TA+)T7(@:&*MM7%Y--CTC8WJGFA:^=U5T:8.*@ LX130A9&"WRY[9H['
M0N@PS":]J.N236A55QGCY5"^F"@UW"ME@B%WQ$K<@DY1WEIES=C;_  9&A8.
MB4&U#9I6#U-_X)G."VJ(4L.H-$.;<[=.VQ= .8%#[H6-0-__-,UV!0H]TI5P
M)Y<A3>EP9CJ3.^9]1HV6/@ XZ5)!5"-H[29FL5<.,YC(+<B(?8-"PLA&3S,V
M_$6W4:XFS6SL620O(+1JF'G433QZ 69*1W!H'6@V%79J;",^XAF\"B+PTS!"
M6_(]9B ZW(2_JF6#NDV66]*A%9*%<\?',$]U2!55WRS)4+J9&\Z:R8][ED-X
MIOV_ %X^HI;>CZ45ZN2%</$?)/6JZX<RGZ#F#@+DW@41WJ3!2.W2,@\DHUSL
M'I56VX4NU"=G<K5"52>'"^K3H\1UL<^YZFJF;U9U-C/OE5+T(?/+"\%\U.S<
MT(V'FJW76G>[K5D4;M*6M9A_EQ:&+OV]W)M$38,%-R9!>\I<HN!&F6ADX'!
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M4$L! A0#%     @ [T$J5'D_3_&Y%   RTL  !$              ( !<@\
M &0R,# X,#ED97@Y.3$N:'1M4$L! A0#%     @ [T$J5#B/9UI. P  ?@L
M !$              ( !6B0  &UG=&$M,C R,C Q,3 N>'-D4$L! A0#%
M  @ [T$J5)@R\K./!@  .D<  !4              ( !UR<  &UG=&$M,C R
M,C Q,3!?;&%B+GAM;%!+ 0(4 Q0    ( .]!*E0=\)$1TP0  ,\L   5
M          "  9DN  !M9W1A+3(P,C(P,3$P7W!R92YX;6Q02P4&      4
,!0!  0  GS,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
